| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972129 | The Journal of Heart and Lung Transplantation | 2009 | 6 Pages |
Abstract
The SHFM can be used to risk-stratify end-stage heart failure patients, provided known markers of increased risk are included such inotrope use and IABP ± ventilator support. The SHFM may facilitate identification of high-risk patients to evaluate for potential LVAD implantation by providing an estimate of 1-year survival with medical therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Wayne C. MD, Dariush MD, DrPH, David T. MD, David J. PhD, Leslie W. MD, REMATCH Investigators REMATCH Investigators,